Archives for: June 13th, 2019

Richard Horowitz, M.D.

Written by NatCapLyme on June 13, 2019

Dr. Richard Horowitz, one of the country’s prominent Lyme and tick-borne disease specialists, recently made a presentation to the National Capital Lyme Disease Association. The title of his presentation was: Precision Medicine for Chronic Lyme and Multiple Systemic Infectious Disease Syndrome (MSIDS).

NatCapLyme Interviews Rapper MC Bugg-Z

Written by NatCapLyme on June 21, 2018

Andy Lima is a tick and mosquito biologist for the Fairfax County Health Department in Fairfax, Virginia. He also shares a passion for rapping and is known as MC Bugg-Z to many.

Gregg P. Skall’s Presentation to the TBD Working Group

Written by NatCapLyme on December 11, 2017

On December 11, 2017, Gregg P. Skall was asked to present the keynote address to HHS’s inaugural TBD Working Group in Washington, DC. Mr. Skall has been the pro bono counsel for the National Capital Lyme and Tick-Borne Disease Association. For these past 20 years, Mr. Skall has passionately advocated for the acknowledgement of Lyme and tick-borne diseases and for the advancement of treatment.

Neil Spector, M.D.

Written by NatCapLyme on November 17, 2017

Dr. Neil Spector, M.D. recently presented to the National Capital Lyme and Tick-Borne Disease Association. The title of his talk was: Analogies between Lyme Borreliosis and Cancer Biology: Therapeutic Implications. His work focuses on the molecular and immunobiology of cancer, which could also lead to a paradigm shift in treatment to a new generation of targeted and immunotherapies to battle Lyme and its co-infections.

Samuel M. Shor, M.D.

Written by NatCapLyme on June 29, 2017

Dr. Samuel M. Shor, M.D. recently made a presentation to the National Capital Lyme Disease Association providing an update on the clinical research he is conducting with Ceres Nanosciences, a Northern Virginian based biotechnology company.

Ying Zhang, MD, PhD

Written by NatCapLyme on February 3, 2017

Dr. Ying Zhang, M.D. recently presented to the membership of the National Capital Lyme Disease Association and the public-at-large at Johns Hopkins Sibley Memorial Hospital in Washington, DC. His informative presentation titled, “Drugs Targeting Borrelia Persisters: Implications for Improved Treatment of Persistent Lyme Disease,” was well received by the audience.